SciCombinator

Discover the most talked about and latest scientific content & concepts.

CP Andam, CJ Worby, R Gierke, L McGee, T Pilishvili and WP Hanage
Abstract
Introduction of 13-valent pneumococcal conjugate vaccine in the United States was not associated with a significant change in prevalence of penicillin resistance in nonvaccine type serotypes because of the variable success of highly resistant serotypes. Differences in regional serotype distribution and serotype-specific resistance contributed to geographic heterogeneity of penicillin resistance.
comments powered by Disqus

* Data courtesy of Altmetric.com